I came to London to report about higher education but I stayed for the austerity.

Chimps Give Way to Chips as Drug Makers Seek Lower Costs

bloomberg.com — To test a potential cure for hepatitis B, Benitec Biopharma Ltd. could have infected as many as 50 chimpanzees with the liver disease, then given them the drug and watched what happened. Instead, the Australian company turned to a U.K. startup for "livers on a chip" contaminated with the virus.

AstraZeneca’s profit dips

iol.co.za — London - AstraZeneca, the second-largest UK drugmaker, said earnings fell in the first quarter as sales of two of its biggest medicines continued to decline and currency fluctuations took a slice from revenue. Profit excluding certain items slipped to $1.37 billion, or $1.08 a share, from $1.47 billion, or $1.17 a share, a year ago, the company said in a statement.

AstraZeneca Profit Falls as Top Drugs Lose Patent Protection

bloomberg.com — AstraZeneca Plc, the second-largest U.K. drugmaker, said earnings fell in the first quarter as sales of two of its biggest medicines continued to decline and currency fluctuations took a slice from revenue. Profit excluding certain items slipped to $1.37 billion, or $1.08 a share, from $1.47 billion, or $1.17 a share, a year ago, the company said in a statement.

Mylan $23 Million Chairman Shows Looming Teva Culture Clash

bloomberg.com — Mylan NV Executive Chairman Robert Coury made $22.7 million, including $1 million for his personal use of the drugmaker's two corporate jets, in 2012 and 2013. At Israeli rival Teva, shareholders in 2012 balked at raising the chairman's salary to $900,000 a year.

Faster FDA Spurs Cancer Breakthroughs

bloomberg.com — (Bloomberg) -- More new drugs are getting the green light in the U.S. as drugmakers take advantage of a speedier metabolism at the Food and Drug Administration. Through March 19, the FDA has approved 10 new drugs, on pace to match last year's total of 41, which was an 18-year high.

Last Mile of Ebola Eradication Is Seen as the Most Difficult

bloomberg.com — (Bloomberg) -- One year after Ebola was declared an epidemic in West Africa, significant progress has been made to eradicate the disease. The last steps are more difficult, according to the United Nations special envoy for the outbreak.

Schools Find Ayn Rand Can’t Be Shrugged as Donors Build Courses

bloomberg.com — May 5 (Bloomberg) -- John Allison, former chairman of bank holding company BB&T Corp., admires author Ayn Rand so much that he devised a strategy to spread her laissez-faire principles on U.S. campuses. Allison, working through the BB&T Charitable Foundation, gives schools grants of as much as $2 million if they agree to create a course on capitalism and make Rand's masterwork, "Atlas Shrugged," required reading.

AstraZeneca Lags in Cancer Race Where Losing May Invite Takeover

bloomberg.com — (Bloomberg) -- Working to fend off a takeover last May, AstraZeneca Plc told investors it could raise its revenue 75 percent by 2023, thanks in part to a robust pipeline of experimental drugs. Almost a year later, those projections look shaky as rivals are moving ahead of the company in immune therapies for cancer, one of the hottest areas of drug development.

CN Bio’s LiverChip Helps Battle Hepatitis B

AstraZeneca heart drug proves worthy, elevating sales potential

livemint.com — Patients now receive drugs such as Brilinta, combined with aspirin, for about a year after a heart attack, then switch to aspirin alone. Photo: AFP London: AstraZeneca Plc. 's Brilinta reduces the risk of death from heart attack or stroke long after an initial attack, according to research that may bring billions of dollars to the company as more people use the drug for extended periods.
More Articles →
May 01, 2015

Women write academic study on gender bias, told to get male co-author if they want it published #cantmakethisup bloomberg.com/news/articles/…

Apr 30, 2015

Guilty as charged RT @karinfischer Clearly an excuse to write 'anteaters & banana slugs' MT @ostaley timeshighereducation.co.uk/world-universi…

Apr 30, 2015

RT @aawayne: Congress thought it fixed the VA last year. Turns out nothing much has changed, @KathleenEMiller reports. bloomberg.com/politics/artic…

Apr 30, 2015

Maybe they can get rid of those Meerkat ads, too RT @charlescwcooke Oh England. I could weep. ccwc.me/1GKb2ku

Apr 30, 2015

RT @david_wainer: But a good quarter for #Teva, beating analyst estimates. Gives it some momentum with Mylan shareholders bloom.bg/1OI00R8 via @business



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Oliver Staley, email ostaley@muckrack.com.


Share This Profile